Marlin Equity Partners recently backed SigmaCare with fresh equity funding. No financial details were disclosed, but SigmaCare CEO Steve Pacicco said the funds will be used for expansion. "The funding from Marlin Equity Partners will allow SigmaCare to expand our nationwide presence, accelerate product innovation and strengthen interoperability initiatives. Marlin's broad resources and expertise make them the right partner to help SigmaCare address the rapidly changing needs of our customers and the market," he said in a press release.
SigmaCare specializes in developing and marketing solutions for the long-term and post-acute care (LTPAC) market. Their aim is to decrease rehospitalizations, lower costs and increase revenue. Marlin Equity Partners, meanwhile, is a private investment firm that invests across multiple industries, including that of the healthcare sector. Its capital under management is pegged at more than USD 2.6 billion.
Group President of Health Care at Marlin Equity Partners Jim Brady said the funding will position SigmaCare at the top of the helm. "With the new funding, SigmaCare is poised to become the national leader in the long-term and post-acute care technology market," he added.
Join the Conversation